Durable responses and long-term progression-free survival observed in a phase II study of MDX-010 alone or in combination with dacarbazine (DTIC) in metastatic melanoma (Q114738626)
scientific article published on 23 February 2017
Language:
Current Data About Durable responses and long-term progression-free survival observed in a phase II study of MDX-010 alone or in combination with dacarbazine (DTIC) in metastatic melanoma
(P31) (Q13442814)
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P304) 7525-7525
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P433) 16_suppl
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P478) 23
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P577) Thursday, February 23, 2017
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P1433) (Q400292)
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P1476) "Durable responses and long-term progression-free survival observed in a phase II study of MDX-010 alone or in combination with dacarbazine (DTIC) in metastatic melanoma" (language: en)
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

(P2093) S. A. Fischkoff
(P1545) 1
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

E. Hersh
(P1545) 2
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

J. Weber
(P1545) 3
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

J. Powderly
(P1545) 4
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

K. Khan
(P1545) 5
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

A. Pavlick
(P1545) 6
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

W. Samlowski
(P1545) 7
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

S. O’Day
(P1545) 8
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

G. Nichol
(P1545) 9
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

M. Yellin
(P1545) 10
(P248)
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525
(P854) https://api.crossref.org/v1/works/http://dx.doi.org/10.1200/JCO.2005.23.16_SUPPL.7525
(P813) Tuesday, October 18, 2022

other details
description scientific article published on 23 February 2017

External Links
(P356) 10.1200/JCO.2005.23.16_SUPPL.7525